Results 311 to 320 of about 371,827 (350)

Peripheral T Cell Lymphoma: an Overview

Leukemia & Lymphoma, 1990
Peripheral T cell lymphoma (PTCL) is a term that encompasses a wide range of histological subtypes of Non-Hodgkin's lymphoma which arise from mature or post-thymic T lymphocytes. These tumours account for 10-20% of all cases of non-Hodgkin's lymphoma in the Western World.
P A, Hall, M A, Richards
openaire   +2 more sources

Peripheral T-cell Lymphomas

2019
Peripheral T-cell lymphomas (PTCLs) account for about 12% of all lymphoid neoplasms in Western Countries. They show an endemic prevalence in some geographic areas, including southern Japan, Caribbean Basin, and regions of Mexico and USA, where they are related to HTVL1 infection.1 PTCLs can be roughly subdivided into specified and not otherwise ...
openaire   +1 more source

Intensive chemotherapy for peripheral T‐cell lymphomas

Hematological Oncology, 1992
AbstractForty‐two patients with previously untreated peripheral T‐cell lymphomas (PTCL) were treated with an intensive chemotherapy protocol. Either the BACOP or the m‐BACOD regimen was used for induction. Patients achieving complete clinical remission after three courses were given intensive consolidation and maintenance chemotherapy similar to the ...
Liang, R, Todd, D, Chan, TK, Chiu, E, Lie, A, Ho, FCS, Loke, SL   +6 more
openaire   +4 more sources

Peripheral T-Cell Non-Hodgkin's Lymphoma

Hematology/Oncology Clinics of North America, 2008
T-cell non-Hodgkin's lymphoma (T-NHL) are uncommon malignancies accounting for 10% to 15% of all NHL. Geographic variation has been well documented, but the geographic variation may reflect exposure to specific pathogenic viruses, such as Epstein Barr Virus and Human T-cell leukemia virus-1 in Asian countries.
openaire   +2 more sources

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Journal of Clinical Oncology, 2008
J. Vose, J. Armitage, D. Weisenburger
semanticscholar   +1 more source

Pathobiology of Peripheral T-cell Lymphomas

Hematology, 2006
AbstractPeripheral T-cell lymphomas (PTLs) are uncommon, accounting for fewer than 10% of all non-Hodgkin lymphomas. Success in therapy of the PTLs has lagged behind that of aggressive B-cell lymphomas, and most PTLs have a poor prognosis. The molecular pathogenesis of most PTLs is also poorly understood.
openaire   +2 more sources

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.

Annals of Oncology, 2015
Y. Shi, M. Dong, X. Hong, W. Zhang, J. Feng, J. Zhu, L. Yu, X. Ke, H. Huang, Z. Shen, Y. Fan, W. Li, X. Zhao, J. Qi, H. Huang, D. Zhou, Z. Ning, X. Lu   +17 more
semanticscholar   +1 more source

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Journal of Clinical Oncology, 2012
B. Coiffier, B. Pro, H. Prince, F. Foss, L. Sokol, M. Greenwood, D. Caballero, P. Borchmann, F. Morschhauser, M. Wilhelm, L. Pinter-Brown, S. Padmanabhan, A. Shustov, J. Nichols, S. Carroll, J. Balser, Barbara Balser, S. Horwitz   +17 more
semanticscholar   +1 more source

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

Peripheral-nitrogen effects on the Ru1 centre for highly efficient propane dehydrogenation

Nature Catalysis, 2022
, Jian Lin, Qiang Wan
exaly